Literature DB >> 8850379

Effect of nicorandil on abnormal coronary flow reserve assessed by exercise 201Tl scintigraphy in patients with angina pectoris and nearly normal coronary arteriograms.

H Yamabe1, H Namura, T Yano, H Fujita, S Kim, M Iwahashi, K Maeda, M Yokoyama.   

Abstract

The purpose of the present study is to assess the effect of nicorandil, a coronary vasodilator with a mechanism of potassium channel opening, on the abnormal myocardial 201Tl perfusion evoked by exercise. Eleven patients who had a history of typical angina, positive exercise electrocardiograms, positive 201Tl scintigraphy, nearly normal coronary arteriograms, and negative coronary vasospasm underwent exercise 201Tl scintigraphies under no medication (baseline test) and administration of nicorandil (nicorandil test). 201Tl was injected at a matched workload in both tests. Nicorandil did not alter heart rate, blood pressure, or the rate-pressure product at the end of the exercise, but it significantly improved the extent score from 0.37 +/- 0.22 to 0.20 +/- 0.15 (p < 0.05) and the severity score from 33.9 +/- 32.2 to 13.5 +/- 16.4 (p < 0.05), and also significantly hastened the 201Tl mean washout rate from 30.5 +/- 14.8% to 37.4 +/- 13.1% (p < 0.05). Anginal symptoms disappeared in 3 of 5 cases and ST depression improved in 5 of 7 cases after nicorandil. We conclude that nicorandil augments coronary flow reserve, possibly due to a reduction of vasotone in the small coronary arteries.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8850379     DOI: 10.1007/bf00879868

Source DB:  PubMed          Journal:  Cardiovasc Drugs Ther        ISSN: 0920-3206            Impact factor:   3.727


  47 in total

Review 1.  "Microvascular angina" as a cause of chest pain with angiographically normal coronary arteries.

Authors:  R O Cannon; S E Epstein
Journal:  Am J Cardiol       Date:  1988-06-01       Impact factor: 2.778

2.  Continuous recording of coronary sinus oxygen saturation during atrial pacing in patients with coronary artery disease or with syndrome X.

Authors:  T Crake; R Canepa-Anson; L Shapiro; P A Poole-Wilson
Journal:  Br Heart J       Date:  1988-01

Review 3.  Pharmacology and therapeutic effects of nicorandil.

Authors:  M Kinoshita; K Sakai
Journal:  Cardiovasc Drugs Ther       Date:  1990-08       Impact factor: 3.727

4.  Improved exercise capacity with acute aminophylline administration in patients with syndrome X.

Authors:  M Emdin; E Picano; F Lattanzi; A L'Abbate
Journal:  J Am Coll Cardiol       Date:  1989-11-15       Impact factor: 24.094

5.  Exercise testing in patients with microvascular angina.

Authors:  S E Epstein; R O Cannon; R O Bonow
Journal:  Circulation       Date:  1991-05       Impact factor: 29.690

6.  Lack of evidence for alpha-adrenergic receptor-mediated mechanisms in the genesis of ischemia in syndrome X.

Authors:  A R Galassi; J C Kaski; G Pupita; M Vejar; F Crea; A Maseri
Journal:  Am J Cardiol       Date:  1989-08-01       Impact factor: 2.778

7.  Diurnal variation in left ventricular function: a study of patients with myocardial ischaemia, syndrome X, and of normal controls.

Authors:  R D Levy; D Cunningham; L M Shapiro; C Wright; L Mockus; K M Fox
Journal:  Br Heart J       Date:  1987-02

8.  Usefulness of changes in exercise tolerance induced by nitroglycerin in identifying patients with syndrome X.

Authors:  M Radice; V Giudici; A Albertini; A Mannarini
Journal:  Am Heart J       Date:  1994-03       Impact factor: 4.749

9.  Abnormal thallium-201 scans in patients with chest pain and angiographically normal coronary arteries.

Authors:  B C Berger; R Abramowitz; C H Park; A G Desai; M T Madsen; E K Chung; A N Brest
Journal:  Am J Cardiol       Date:  1983-08       Impact factor: 2.778

10.  Mechanism of angina pectoris in patients with systemic hypertension and normal epicardial coronary arteries by arteriogram.

Authors:  S Scheler; W Motz; B E Strauer
Journal:  Am J Cardiol       Date:  1994-03-01       Impact factor: 2.778

View more
  5 in total

1.  Angina in Women without Obstructive Coronary Artery Disease.

Authors:  Kamakki Banks; Monica Lo; Amit Khera
Journal:  Curr Cardiol Rev       Date:  2010-02

Review 2.  Coronary microvascular disease: current concepts of pathophysiology, diagnosis and management.

Authors:  Aish Sinha; Haseeb Rahman; Divaka Perera
Journal:  Cardiovasc Endocrinol Metab       Date:  2020-07-16

Review 3.  Microvascular angina: angina that predominantly affects women.

Authors:  Jin Joo Park; Sung-Ji Park; Dong-Ju Choi
Journal:  Korean J Intern Med       Date:  2015-02-27       Impact factor: 2.884

Review 4.  Vasodilator Therapy: Nitrates and Nicorandil.

Authors:  Jason M Tarkin; Juan Carlos Kaski
Journal:  Cardiovasc Drugs Ther       Date:  2016-08       Impact factor: 3.727

5.  The effect of nicorandil in patients with cardiac syndrome X: A meta-analysis of randomized controlled trials.

Authors:  Qiulei Jia; Shuqing Shi; Guozhen Yuan; Jingjing Shi; Shuai Shi; Yi Wei; Yuanhui Hu
Journal:  Medicine (Baltimore)       Date:  2020-09-11       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.